Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-May-24 4:15 PM View:  | Carson William H. Director | Annexon, Inc. (ANNX) | 01-May-24 | Private Purchase (Planned) | 3,200 | $4.68 | $14,982.40 | 100% 3.2K to 6.4K | |
| 10-Apr-24 7:17 PM View: | Carson William H. Director | Annexon, Inc. (ANNX) | 08-Apr-24 | Private Purchase (Planned) | 3,200 | $6.07 | $19,411.20 | 100% 0 to 3.2K | |
| 21-Feb-24 4:31 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 20-Feb-24 | Sale | 2,593 | $5.53 | $14,339.30 | (3%) 84.65K to 82.06K | |
| 21-Feb-24 4:31 PM View: | Yednock Ted EVP & Chief Innovation Officer | Annexon, Inc. (ANNX) | 20-Feb-24 | Sale | 2,604 | $5.51 | $14,348.00 | (3%) 96.08K to 93.47K | |
| 21-Feb-24 4:31 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 20-Feb-24 | Sale | 1,951 | $5.48 | $10,691.50 | (2%) 87.59K to 85.64K | |
| 21-Feb-24 4:32 PM View: | Artis Dean Richard EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 77% 50.33K to 89.33K | |
| 21-Feb-24 4:31 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 85% 45.65K to 84.65K | |
| 21-Feb-24 4:32 PM View: | Dananberg Jamie Chief Medical Officer | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 100% 0 to 39.0K | |
| 21-Feb-24 4:31 PM View: | Yednock Ted EVP & Chief Innovation Officer | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 68% 57.08K to 96.08K | |
| 21-Feb-24 4:31 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 16-Feb-24 | Grant | 39,000 | -- | -- | 80% 48.59K to 87.59K | |
| 14-Feb-24 7:56 PM View: | Love Douglas PRESIDENT AND CEO Director | Annexon, Inc. (ANNX) | 12-Feb-24 | Sale | 5,782 | $5.54 | $32,032.30 | (3%) 201.9K to 196.12K | |
| 14-Feb-24 7:54 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 12-Feb-24 | Sale | 1,809 | $5.54 | $10,021.90 | (4%) 47.46K to 45.65K | |
| 14-Feb-24 7:52 PM View: | Yednock Ted EVP & Chief Innovation Officer | Annexon, Inc. (ANNX) | 12-Feb-24 | Sale | 1,810 | $5.54 | $10,027.40 | (3%) 58.88K to 57.08K | |
| 14-Feb-24 7:59 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 12-Feb-24 | Sale | 1,349 | $5.53 | $7,459.97 | (3%) 49.94K to 48.59K | |
| 29-Dec-23 4:12 PM View: | Yednock Ted EVP & Chief Innovation Officer | Annexon, Inc. (ANNX) | 27-Dec-23 | Planned Option Sale | 21,000 | $4.52 | $94,966.20 | (100%) 21.0K to 0 | |
| 29-Dec-23 4:12 PM View: | Yednock Ted EVP & Chief Innovation Officer | Annexon, Inc. (ANNX) | 27-Dec-23 | Option Exercise | 21,000 | $1.63 | $34,176.20 | 100% 0 to 21.0K | |
| 28-Dec-23 4:30 PM View: | Satter Muneer A Director 10% Owner | Annexon, Inc. (ANNX) | 26-Dec-23 | Private Purchase | 350,000 | $2.88 | $1,008,000.00 | 5% 7.06M to 7.41M | |
| 23-Jan-24 4:57 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 11-Jul-23 | Sale | 1,057 | $3.84 | $4,054.76 | (2%) 48.52K to 47.46K | |
| 23-Jan-24 4:58 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 11-Jul-23 | Sale | 978 | $3.84 | $3,751.71 | (2%) 46.78K to 45.8K | |
| 30-May-23 9:54 PM View: | Bain Capital Life Sciences ... 10% Owner | Annexon, Inc. (ANNX) | 25-May-23 | Private Purchase | 300,000 | $2.13 | $639,720.00 | 6% 5.4M to 5.7M | |
| 21-Feb-23 5:26 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 16-Feb-23 | Grant | 18,975 | -- | -- | 64% 29.54K to 48.52K | |
| 21-Feb-23 5:27 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 16-Feb-23 | Grant | 18,975 | -- | -- | 68% 27.8K to 46.78K | |
| 17-Feb-23 5:12 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 15-Feb-23 | Sale | 6,571 | $5.87 | $38,563.90 | (3%) 204.22K to 197.65K | |
| 15-Feb-23 6:59 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 14-Feb-23 | Sale | 166 | $6.30 | $1,046.30 | (< 1%) 29.71K to 29.54K | |
| 15-Feb-23 7:00 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 14-Feb-23 | Sale | 144 | $6.30 | $907.10 | (< 1%) 27.95K to 27.8K | |
| 15-Feb-23 6:59 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 13-Feb-23 | Sale | 1,742 | $6.31 | $10,988.70 | (6%) 31.45K to 29.71K | |
| 15-Feb-23 7:00 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 13-Feb-23 | Sale | 1,501 | $6.30 | $9,461.10 | (5%) 29.45K to 27.95K | |
| 14-Feb-23 4:31 PM View: | Satter Muneer A Director 10% Owner | Annexon, Inc. (ANNX) | 10-Feb-23 | Private Purchase | 2,647,060 | $6.80 | $18,000,000.00 | 60% 4.41M to 7.06M | |
| 13-Jul-22 7:40 PM View: | Mattheakis Larry EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 11-Jul-22 | Grant Duplicate | 4,688 | -- | -- | 38% 12.5K to 17.19K | |
| 13-Jul-22 6:48 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 11-Jul-22 | Grant | 9,375 | -- | -- | 65% 14.5K to 23.88K | |
| 13-Jul-22 7:37 PM View: | Mattheakis Larry EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 11-Jul-22 | Grant | 4,688 | -- | -- | 38% 12.5K to 17.19K | |
| 13-Jul-22 7:49 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 11-Jul-22 | Grant | 9,375 | -- | -- | 75% 12.5K to 21.88K | |
| 11-Jul-22 8:42 PM View: | Satter Muneer A Director | Annexon, Inc. (ANNX) | 07-Jul-22 | Private Purchase | 2,453,990 | $3.84 | $9,423,310.00 | 126% 1.95M to 4.41M | |
| 18-Apr-22 7:04 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 14-Apr-22 | Private Purchase | 60,000 | $2.45 | $146,814.00 | 43% 140.94K to 200.94K | |
| 15-Feb-22 4:35 PM View: | Mattheakis Larry EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 15-Feb-22 4:37 PM View: | Keswani Sanjay EVP & Chief Medical Officer | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 15-Feb-22 4:38 PM View: | Overdorf Michael EVP & Chief Business Officer | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 12,500 | -- | -- | 100% 0 to 12.5K | |
| 15-Feb-22 4:39 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 40,000 | -- | -- | 40% 100.94K to 140.94K | |
| 15-Feb-22 4:36 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 11-Feb-22 | Grant | 12,500 | -- | -- | 625% 2.0K to 14.5K | |
| 15-Nov-21 6:05 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 11-Nov-21 | Option Exercise | 100,942 | $1.54 | $155,503.00 | 100% 0 to 100.94K | |
| 20-Sep-21 5:46 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 16-Sep-21 | Option Exercise | 7,500 | $1.41 | $10,572.00 | 100% 0 to 7.5K | |
| 20-Sep-21 5:46 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 16-Sep-21 | Market Option Sale (Planned) | 7,500 | $22.05 | $165,340.00 | (100%) 7.5K to 0 | |
| 15-Sep-21 6:35 PM View: | Yednock Ted EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 13-Sep-21 | Option Exercise | 16,190 | $1.68 | $27,224.70 | 100% 0 to 16.19K | |
| 15-Sep-21 6:35 PM View: | Yednock Ted EVP & Chief Scientific Officer | Annexon, Inc. (ANNX) | 13-Sep-21 | Market Option Sale (Planned) | 16,190 | $20.00 | $323,860.00 | (100%) 16.19K to 0 | |
| 15-Sep-21 6:35 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 13-Sep-21 | Market Option Sale (Planned) | 3,500 | $20.01 | $70,033.60 | (64%) 5.5K to 2.0K | |
| 15-Sep-21 6:35 PM View: | Lew Jennifer EVP & Chief Financial Officer | Annexon, Inc. (ANNX) | 13-Sep-21 | Option Exercise | 3,500 | $7.49 | $26,209.80 | 175% 2.0K to 5.5K | |
| 09-Jun-21 4:32 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 08-Jun-21 | Option Exercise | 3,750 | $1.41 | $5,286.00 | 100% 0 to 3.75K | |
| 09-Jun-21 4:32 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 08-Jun-21 | Market Option Sale (Planned) | 3,750 | $22.55 | $84,562.50 | (100%) 3.75K to 0 | |
| 09-Jun-21 4:32 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 07-Jun-21 | Option Exercise | 3,750 | $1.41 | $5,286.00 | 100% 0 to 3.75K | |
| 09-Jun-21 4:32 PM View: | Love Douglas President & CEO Director | Annexon, Inc. (ANNX) | 07-Jun-21 | Market Option Sale (Planned) | 3,750 | $22.31 | $83,667.40 | (100%) 3.75K to 0 |
